Abstract
The possibility of controlling cancer by immunological means continues to provoke the interest and excitement of many workers. Such a possibility, however, is entirely dependent on the fact that tumors express antigens which are associated with those tumors. Efforts have been made to demonstrate tumor antigenicity by serological methods. As early as 1930, Witebsky produced in guinea pigs a putative antiserum to a human stomach cancer. After adsorption of this antiserum with extracts of normal human stomach, he found that it was still capable of producing a precipitation reaction with the cancer extract. This work suggested that an antigen was present in a cancerous stomach which was not present in a normal stomach. Other serological evidence followed. Graham and Graham (1955) claimed the ability to demonstrate positive complement fixation reactions for some patients using extracts of autologous tumors. Other claims were made (Finney et al., 1960) for the demonstration of precipitating antibody in the sera of cancer patients against extracts of their own tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ambus, U., Mavligit, G. M., Gutterman, J. U., McBride, C. M., and Hersh, E. M., 1974, Specific and non-specific immunologic reactivity of regional lymph node lymphocytes in human malignancy, Int. J. Cancer 14: 291–300.
Andersen, V., Bendixen, G., and Schiodt, T., 1969, An in vitro demonstration of cellular immunity against autologous mammary carcinoma in man, Acta Med. Scand. 186: 101–103.
Bach, F. H., 1974, Normal histocompatibility antigens as a model for tumors, Am. J. Clin. Pathol. 62: 173–183.
Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature (London) New Biol. 238: 185–187.
Baldwin, R. W., Embleton, M. J., and Price, M. R., 1973a, Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumor membrane fractions, Int. J. Cancer 12: 84–92.
Baldwin, R. W., Embleton, M. J., and Robins, R. A., 1973b, Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status, Int. J. Cancer 11: 1–10.
Barna, B., and Deodhar, S. D., 1975, The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors, Cancer Res. 35: 920–926.
Berg, J. W., 1956, Sinus histiocytosis: A fallacious measure of host resistance to cancer, Cancer 9: 935–939.
Berg, J. W., 1959, Inflammation and prognosis in breast cancer, Cancer 12: 714–720.
Berlinger, N. T., and Good, R. A., 1976, Concomitant immunopathology with squamous cell carcinomas of the head and neck regions,Trans. Am. Acad. Ophthalmol. Otolatyngol. 82:ORL588–594.
Berlinger, N. T., Lopez, C., and Good, R. A., 1976a, Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells, Nature (London) 260: 145–146.
Berlinger, N. T., Tsakraklides, V., Pollak, K., Adams, G. L., Yang, M., and Good, R. A., 1976b, Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma, Cancer 37: 697–705.
Berlinger, N. T., Lopez, C., Vogel, J. E., Lipkin, M., and Good, R. A., 1977. Defective recognitive immunity in family aggregates of colon carcinoma, J. Clin. Invest. 59: 761–769.
Black, M. M., and Speer, F. D., 1958, Sinus histiocytosis of lymph nodes in cancer, Surg. Gynecol. Obstet. 106: 163–175.
Black, M. M., Kerpe, S., and Speer, F. D., 1953, Lymph node structure in patients with cancer of the breast, Am. J. Pathol. 29: 505–521.
Black, M. M., Opler, S. R., and Speer, F. D., 1954, Microscopic structure of gastric carcinomas and their regional lymph nodes in relation to survival, Surg. Gynecol. Obstet. 98: 725–734.
Bloom, B. R., Bennett, B., Oettgen, H. F., McLean, E. P., and Old, L. J., 1969, Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration,Proc. Natl. Acad. Sci. USA 64: 1176–1180.
Bolton, P. M., Mander, A. M., Davidson, J. M., James, S. L., Newcombe, R. G., and Hughes, L. E., 1975, Cellular immunity in cancer: Comparison of delayed hypersensitivity skin tests in three common cancers, Br. Med. J. 3: 18–20.
Bone, G., and Camplejohn, R., 1973, The role of cellular immunity in control of neoplasia, Br. J. Surg. 60: 824–827.
Bone, G., and Lauder, I., 1974, Cellular immunity, peripheral blood lymphocyte count, and pathological staging of tumors in the gastrointestinal tract, Br. J. Cancer 30:215–221.
Buchanan, W. W., Anderson, J. R., Goudie, R. B., and Gray, K. G., 1958, A skin test in thyroid disease, Lancet 2: 928–931.
Bull, D. M., Leibach, J. R., Williams, M. A., and Helms, R. A., 1973, Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration, Science 181: 957–959.
Cantrell, E. G., 1969, Nephrotic syndrome cured by removal of gastric carcinoma, Br. Med. J. 2: 739–740.
Carr, I., Underwood, J. C. E., McGinty, F., and Wood, P., 1974, The ultrastructure of the local lymphoreticular response to an experimental neoplasm, J. Pathol. 113: 175–182.
Chakravorty, R. C., Curutchet, H. P., Coppolla, F. S., Park, C. M., Blaylock, W. K., and Lawrence, Jr., W., 1973, The delayed hypersensitivity reaction in the cancer patient: Observations on sensitization by DNCB, Surgery 73: 730–735.
Costanza, M. E., Pinn, V. P., Schwartz, R. S., and Nathanson, L., 1973, Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome,N. Eng. J. Med. 289: 520–522.
Couser, W. G., Wagonfeld, J. B., Spargo, B. H., and Lewis, E. J., 1974, Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma, Am. J. Med. 57: 962–970.
Creagan, E. T., and Fraumeni, J. F., Jr., 1973, Familial gastric cancer and immunologic abnormalities, Cancer 32: 1325–1331.
DiRe, J. J., and Lane, N., 1963, The relation of sinus histiocytosis in axillary lymph nodes to the surgical curability of carcinoma of the breast, Am. J. Clin. Pathol. 40: 508–515.
Eilber, F. R., and Morton, D. L., 1970, Impaired immunologic reactivity and recurrence following cancer surgery, Cancer 25: 362–367.
Elias, E. G., and Elias, L. L., 1975, Some immunologic characteristics of carcinoma of the colon and rectum, Surg. Gynecol. Obstet. 141: 715–718.
Epstein, W. L., Sagabeil, R., Spider, L., Wybran, J., Reed, W. B., and Blois, M. S., 1973, Halo nevi and melanoma, J. Am. Med. Assoc. 225: 373–377.
Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14: 468–473.
Fass, L., Ziegler, J. L., Herberman, R. B., and Kiryabwire, J. W. M., 1970, Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells, Lancet 1: 116–118.
Finney, J. W., Byers, E. H., and Wilson, R. H., 1960, Studies in tumor auto-immunity, Cancer Res. 20: 351–356.
Froom, D. W., Franklin, W. A., Hano, J. E., and Potter, E. V., 1972, Immune deposits in Hodgkin’s disease with nephrotic syndrome, Arch. Pathol. 94: 547–553.
Ghosh, L., and Muehrcke, R. C., 1970. The nephrotic syndrome: A prodrome to lymphoma, Ann. Intern. Med. 72: 379–382.
Golub, S. H., O’Connell, T. X., and Morton, D. L., 1974, Correlation of in vitro and in vivo assays of immunocompetence in cancer patients, Cancer Res. 34: 1833–1837.
Graham J. B., and Graham, R. M., 1955, Antibodies elicited by cancer in patients, Cancer 8: 409416.
Graham, R. M., and Graham, J. B., 1966, Mast cells and cancer of the cervix, Surg. Gynecol. Obstet. 123: 3–9.
Guillou, P. J., and Giles, G. R., 1973, Inhibition of leukocyte migration by tumor-associated antigens of the colon and rectum, Gut 14: 733–738.
Guillou, P. J., Brennan, T. G., and Giles, G. R., 1975, A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leukocyte migration technique, Gut 16: 290–297.
Han, T., and Takita, H., 1972, Impaired lymphocyte responses to allogeneic cultured lymphoid cells in patients with lung cancer, N. Eng. J. Med. 286: 605–606.
Hawley, P. R., Westerholm, P., and Morson, B. C., 1970, Pathology and prognosis of carcinoma of the stomach, Br. J. Surg. 57: 877–883.
Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., 1968, Cellular and humoral immunity to different types of human neoplasms, Nature (London) 220: 1352–1354.
Hellströ I., Hellströ K. E., and Shepard, T. H., 1970, Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium, Int. J. Cancer 6: 346–351.
Hellström, I., Hellström, K. E., Sjögren, H. O., and Warner, G. A., 1971a, Demonstration of cell-mediated immunity to human neoplasms of various histological types, Int. J. Cancer 7: 1–16.
Hellström, I., Sjögren, H. O., Warner, G., and Hellström, K. E., 1971b, Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms, Int. J. Cancer 7: 226–237.
Herberman, R. B., and Oren, M. E., 1969, Delayed cutaneous hypersensitivity reactions to mem- brane extracts of human tumor cells, Clin. Res. 17: 403.
Hollinshead, A., Glew, D., Bunnag, B., Gold, P., and Herberman, R., 1970, Skin-reactive soluble antigen from intestinal cancer cell membranes and relationship to carcinoembryonic antigens, Lancet 1: 1191–1195.
Hollinshead, A., McWright, C. G., Alford, T. C., and Glew, D. H., 1972, Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold, Science 177: 887–889.
House, A. K., Wisniewski, S., and Woodings, T. L., 1975, Immunity in colonic tumor patients after operation: Determination of leukocyte migration inhibition, Dis. Col. Rect. 18: 100–106.
Hoy, W. E., and Nelson, D. S., 1969, Delayed-type hypersensitivity in mice after skin and tumour allografts and tumour isografts, Nature (London) 222: 1001–1003.
Hughes, L. E., and Lytton, B., 1964, Antigenic properties of human tumors: Delayed cutaneous hypersensitivity reactions, Br. Med. J. 1: 209–212.
Hughes, L. E., and Mackay, W. D., 1965, Suppression of the tuberculin response in malignant disease, Br. Med. J. 2: 1346–1348.
Inokuchi, K., Inutsuka, S. Furusawa, M., Soejima, K., and Ikeda, T., 1967, Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of the stomach, Cancer 20: 1924–1929.
Jacobs, J. B., Edelstein, L. M., Snyder, L. M., and Fortier, N., 1975, Ultrastructural evidence for destruction in the halo nevus, Cancer Res. 35: 352–357.
Kirchner, H. T. M., Chused, T. M., Herberman, R. B., Holden, H. T., and Laurin, D. H., 1974, Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus, J. Exp. Med. 139: 1473–1484.
Koffler, D., Agnello, V., Thoburn, R., and Kunkel, H. G., 1971, Systemic lupus erythematosus: Prototype of immune complex nephritis in man, J. Exp. Med. 134: 169s - 179s.
Kronman, B. S., Shapiro, H. M., and Localio, S. A., 1972, Newer concepts of cancer of the colon and rectum: Delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors, Dis. Col. Rect. 15: 106–110.
Lee, J. C., Yamauchi, H., and Hopper, J., 1966, The association of cancer and the nephrotic syndrome, Ann. Intern. Med. 64: 41–51.
Lejtenyi, M. C., Freedman, S. O., and Gold, P., 1971, Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system, Cancer 28: 115–120.
Lerner, A. B., 1971, On the etiology of vitiligo and gray hair, Am. J. Med. 51: 141–147.
Lewis, M. G., and Copeman, P. W. M., 1972, Halo naevus: A frustrated malignant melanoma, Br. Med. J. 2: 47–48.
Lewis, M. G., Loughridge, L. W., and Phillips, T. M., 1971, Immunological studies in nephrotic syndrome associated with extrarenal malignant disease, Lancet 2: 134–135.
Loughridge, L. W., and Lewis, M. G., 1971, Nephrotic syndrome in malignant diseases of non-renal origin, Lancet 1: 256–258.
Lynch, H. T., 1974, Familial cancer prevalence spanning eight years, Arch. Intern. Med. 134: 931938.
MacCarty, W. C., 1922, Factors which influence longevity in carcinoma, Ann. Surg. 76: 9–12.
Mehlman, D. J., Bulkley, B. H., and Wiermk, P. H., 1971, Serum alpha-fetoglobulin with gastric and prostatic carcinomas, N. Eng. J. Med. 285: 1060–1061.
Mellors, R. C., Aoki, T., and Huebner, R., 1968, Further implication of murine leukemia-like virus in the disorders of NZB mice, J. Exp. Med. 129: 1045–1061.
Mikulska, Z. B., Smith, S., and Alexander, P., 1966, Evidence for an immunological reaction of the host directed against its own actively growing primary tumor, J. Natl. Cancer Inst. 36: 2935.
Miller, C. L., and Mishell, R. F., 1975, Differential regulatory effects of accessory cells in the generation of cell-mediated immune reactions, J. Immunol. 114: 692–695.
Monafo, W. W., Jr., Krause, G. L., Jr., and Medina, J. G., 1962, Carcinoma of the stomach: Morphological characteristics affecting survival, Arch. Surg. 85: 754–763.
Morrison, A. S., Lowe, C. R., MacMahon, B., Yuasa, S., and Warram, J. H., 1972, Survival of breast cancer patients related to incidence risk factors, Int. J. Cancer 9: 470–476.
Morrison, A. S., Black, M. M., Lowe, C. R., MacMahon, B., and Yuasa, S., 1973, Some interna- tional differences in histology and survival in breast cancer, Int. J. Cancer 11: 261–267.
Murgita, R. A., and Tomasi, Jr., T. B., 1975, Suppression of the immune response by alphafetoprotein. II. The effect of mouse alpha-fetoprotein on mixed lymphocyte reactivity and mitogen induced lymphocyte transformation, J. Exp. Med. 141: 440–452.
Nairn, R. C., Nind, A. P. P., Guli, E. P. G., Davies, D. H., Rolland, J. M., McGiven, A. R., and Hughes, E. S. R., 1971, Immunological reactivity in patients with carcinoma of the colon, Br. Med. J. 4: 706–709.
Oort, J., and Turk, J. L., 1965, A histological and autoradiographic study of lymph nodes during the development of contact sensitivity in the guinea pig, Br. J. Exp. Pathol. 46: 147–154.
Oppenheim, J. J., Wang, T., and Frei, E., 1965, The effect of skin homograft rejection on recipient and donor mixed leukocyte cultures, J. Exp. Med. 122: 651–654.
Parrott, D. M. V., 1967, The response of draining lymph nodes to immunological stimulation in intact and thymectomized animals, Symp. Tissue Org. Transpl. Suppl. J. Clin. Pathol. 20: 456465.
Patt, D. J., Brynes, R. K., Vardiman, J. W., and Coppelson, L. W., 1975, Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: An immunomorphologic study, Cancer 35: 1388–1397.
Pick, E., and Turk, J. L., 1972, The biological activities of soluble lymphocyte products, Clin. Exp. Immunol. 10: 1–23.
Pihl, E., Hughes, E. S. R., Nind, A. P. P., and Nairn, R. C., 1975, Colonic carinoma: Clinocopathological correlation with immunoreactivity, Br. Med. J. 3: 742–743.
Pope, B. L., Whitney, R. B., Levy, J. G., and Kilburn, D. G., 1976, Suppressor cells in the spleens of tumor-bearing mice: Enrichment by centrifugation on hypaque-ficoll and characterixation of the suppressor population, J. Immunol. 116: 1342–1346.
Rode, H. N., and Gordon, J., 1974, Macrophages in the mixed leukocyte culture reaction (MLC), Cell. Immunol. 13: 87–94.
Schultz, R. M., Woods, W. A., and Chirigos, M. A., 1975, Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum, Int. J. Cancer 16: 16–23.
Scothorne, R. J., and McGregor, I. A., 1955, Cellular changes in lymph nodes and spleen following skin homografting in the rabbit, J. Anat. 89: 283–292.
Segall, A., Weiler, O., Genin, J., Lacour, J., and Lacour, F., 1972, In vitro study of cellular immunity against autochthonous human cancer, Int. J. Cancer 9: 417–425.
Sherman, R. L., Susin, M., Weksler, M. E., and Becker, E. L., 1972, Lipoid nephrosis in Hodgkin’s disease, Am. J. Med. 52: 699–706.
Sjögren, H. O., Hellströ I., Bansal, S. C., Warner, G. A., and Hellströ K. E., 1972, Elution of “blocking factors” from human tumors capable of abrogating tumor cell destruction by specifically immune lymphocytes, Int. J. Cancer 9: 274–283.
Soborg, M., 1967, In vitro detection of cellular hypersensitivity in man: Specific migration inhibi- tion of white blood cells from brucella-positive persons, Acta Med. Scand. 182: 167–174.
Straus, E., Vernace, S., Janowitz, H., and Paronetto, F., 1975, Migration of peripheral leukocytes in the presence of carcinoembryonic antigen: Studies in patients with chronic inflammatory diseases of the intestine and carcinoma of the colon and pancreas, Proc. Soc. Exp. Biol. Med. 148: 494–497.
Steiner, P. E., Maimon, S. N., Palmer, W. L., and Kirsner, J. B., 1948, Gastric cancer: Morphologic factors in 5-year survival after gastrectomy, Am. J. Pathol. 24: 947–969.
Stewart, T. H. M., 1969, The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors, Cancer 23: 1368–1379.
Takahashi, K., 1961, Squamous cell carcinoma of the esophagus: Stromal inflammatory cell infiltration as a prognostic factor, Cancer 14: 921–933.
Todaro, G. J., and Aaronson, S. A., 1969, Properties of clonal lines of murine sarcoma virus transformed Balb/3T3 cells, Virology 38: 174–179.
Tsakraklides, V., Anastassiades, O. T., and Kersey, J. H., 1973, Prognostic significance of regional lymph node histology in uterine cervical cancer, Cancer 31: 860–868.
Tsakraklides, V., Olson, P., Kersey, J. H., and Good, R. A., 1974, Prognostic significance of regional lymph node histology in cancer of the breast, Cancer 34: 1259–1267.
Tsakraklides, V., Wanebo, H. J., Sternberg, S. S., Stearns, M., and Good, R. A., 1975, Prognostic evaluation of regional lymph node morphology in colorectal cancer, Am. J. Surg. 129: 174–180.
Twomey, J. J., 1974, Abnormalities in the mixed leukocyte reaction during infectious mononucleosis, J. Immunol. 112: 2278–2281.
Twomey, J. J., and Sharkey, 0., 1972, An adaptation of the mixed leukocyte culture test for use in evaluating lymphocyte and macrophage function, J. Immunol. 108: 984–990.
Twomey, J. J., Sharkey, O., Jr., Brown, J. A., Laughter, A. H., and Jordan, P. H., Jr., 1970, Cellular requirements for the mitotic response in allogeneic mixed leukocyte cultures, J. Immunol. 104: 845–853.
Underwood, J. C. E., 1974, Lymphoreticular infiltration in human tumours: Prognostic and biological implications: A review, Br. J. Cancer 30: 538–548.
Wagner, H., 1972, The correlation between the proliferation and cytotoxic responses of mouse lymphocytes to allogeneic cells in vitro, J. Immunol. 109: 630–637.
Wang, M., 1968, Delayed hypersensitivity to extracts from primary sarcomata in the autochthonous host, Int. J. Cancer 3: 483–490.
Wartman, W. B., 1959, Sinus cell hyperplasia of lymph nodes regional to adenocarcinoma of the breast and colon, Br. J. Cancer 13: 389–397.
Wolberg, W. H., and Goelzer, M. L., 1971, In vitro assay of cell mediated immunity in human cancer: Definition of leukocyte migration inhibitory factor, Nature (London) 229: 632–633.
Yoon, I. L., 1959, The eosinophil and gastrointestinal carcinoma, Am. J. Surg. 97: 195–200.
Zöller, M., Price, M. R., and Baldwin, R. W., 1976, Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts, Int. J. Cancer 17: 129–137.
Brent, L., Brown, J., and Medawar, P. B., 1958, Skin transplantation immunity in relation to hypersensitivity, Lancet 2: 561–564.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer Science+Business Media New York
About this chapter
Cite this chapter
Berlinger, N.T. (1978). Recognitive Immunity in Colon Cancer. In: Lipkin, M., Good, R.A. (eds) Gastrointestinal Tract Cancer. Sloan-Kettering Institute Cancer Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2442-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2442-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2444-7
Online ISBN: 978-1-4684-2442-3
eBook Packages: Springer Book Archive